1. Vioxx: lessons for Health Canada and the FDA;Anon.;Can. Med. Assoc. J.,2005
2. Center for Drug Evaluation and Research, 1996. Priority review policy. Manual of Policies and Procedures, MAPP 6020.3. Food and Drug Administration, Rockville, MD. URL: http://www.fda.gov/cder/mapp/6020-3.pdf (accessed: February 4, 2005)
3. Center for Drug Evaluation and Research, 2003. CDER 2003 Report to the nation: improving public health through human drugs. Food and Drug Administration, Rockville, MD. URL: http://www.fda.gov/cder/reports/rtn/2003/rtn2003.pdf (accessed: February 4, 2005)
4. Pharmacopolitics: drug regulation in the United States and Germany;Daemmrich,2004
5. Food and Drug Administration, 2002. FDA amends its regulations to provide for approval of certain new pharmaceutical products based on animal efficacy data. FDA, Rockville, MD. URL: http://www.fda.gov/bbs/topics/NEWS/2002/NEW00811.html (accessed: February 4, 2005)